Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Developmental pluripotency associated 2 pseudogene 1 (DPPA2P1) is a non-functional genomic sequence classified as a pseudogene, corresponding to the DPPA2 gene[3][5][1][10]. Pseudogenes are segments of DNA that resemble functional genes but typically lack the ability to encode a protein due to mutations or truncations. DPPA2P1 does not produce a functional protein product and thus does not directly participate in biological processes, molecular pathways, or have established roles in health or disease. DPPA2P1 is sometimes referenced in genomic studies as a homolog to the functional DPPA2 gene, which plays a role in early embryonic development and pluripotency. However, DPPA2P1 itself does not act as a direct biological or pharmacological target and there are no known drugs or disease associations linked specifically to this pseudogene. Summary judgment: DPPA2P1 is not a therapeutic target and is not functionally relevant as a receptor, enzyme, drug target, or biomarker. Its inclusion in databases is primarily for genomic annotation, and not for therapeutic intervention or biological function[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Developmental pluripotency associated 2 pseudogene 1 (DPPA2P1).